Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)
| 0.60 BATS BZX Real-Time Price As of 9:49am ET |  +0.0097 / +1.64%Today’s Change | 0.53 Today|||52-Week Range 3.27 | -10.04% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 20.4M | 16.5M | 23.9M | 17.5M | |
| Short Term Investment Cash | -3.7M | -3.9M | 7.4M | -6.4M | ||
| Cash & Short Term Investments | 20.4M | 16.5M | 23.9M | 17.5M | ||
| Receivables | Receivables | 3.0M | 2.1M | 1.5M | 1.5M | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Prepaid Expenses | 893.0K | 867.0K | 363.0K | 543.0K | |
| Other Current Assets | 207.0K | 173.0K | 213.0K | 236.0K | ||
| Current Assets | 24.6M | 19.6M | 26.0M | 19.8M | ||
| Total Assets | Property, Plant and Equipment - Gross | 7.8M | 6.4M | 6.9M | 6.2M | |
| Depreciation | -7.6M | -6.3M | -6.9M | -6.1M | ||
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Total Assets | 24.8M | 19.7M | 26.0M | 19.8M | ||
| Liabilities | Accounts Payable | 1.9M | 2.5M | 1.6M | 2.7M | |
| Accrued Expenses | 3.7M | 2.3M | 1.9M | 1.4M | ||
| Other Current Liabilities | 3.8M | 2.8M | 2.6M | 1.7M | ||
| Other Liabilities | 5.8M | 5.3M | 4.1M | 4.5M | ||
| Total Liabilities | Other Liabilities | 176.0K | 130.0K | 124.0K | 100.0K | |
| Total Liabilities | 5.9M | 5.4M | 4.2M | 4.6M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 18.8M | 14.3M | 21.8M | 15.3M | ||
| Total Shareholder Equity | 18.8M | 14.3M | 21.8M | 15.3M | ||
| Share Information | Common Shares Outstanding | 3.0M | 4.3M | 12.0M | 12.5M | |
| Addtl. Info. | No data currently available for this section. | |||||
